Condition: Exocrine Pancreatic Insufficiency (EPI) · Cystic Fibrosis (CF) · Sponsor: Anagram Therapeutics, Inc.
In this study, ANG003, a pancreatic enzyme replacement therapy (PERT; commonly called "enzymes"), is being investigated as a potential treatment for exocrine pancreatic insufficiency (EPI). People with EPI due to Cystic Fibrosis (CF) may be eligible to participate in this study. The primary objective of this study is to evaluate the safety of ANG003 and see if it works as well compared to Creon, an approved PERT.
This description comes directly from the study's public registry record.
Evan Bailey, MD · 617-466-3111 · medical@anagramtx.com
Always discuss trial participation with your own doctor first.
| Long Beach Memorial Medical Center | Long Beach, California, United States | Recruiting |
| Center for Cystic Fibrosis at Keck Medical Center of USC | Los Angeles, California, United States | Not Yet Recruiting |
| National Jewish Health | Denver, Colorado, United States | Not Yet Recruiting |
| University of Florida | Gainesville, Florida, United States | Not Yet Recruiting |
| Central Florida Pulmonary Group | Orlando, Florida, United States | Not Yet Recruiting |
| The Cystic Fibrosis Institute | Glenview, Illinois, United States | Recruiting |
| University of Iowa | Iowa City, Iowa, United States | Not Yet Recruiting |
| University of Kansas Medical Center | Kansas City, Kansas, United States | Not Yet Recruiting |
| University of Kentucky | Lexington, Kentucky, United States | Not Yet Recruiting |
| MaineHealth Pediatric Specialty Care | Portland, Maine, United States | Not Yet Recruiting |
| Massachusetts General Hospital | Boston, Massachusetts, United States | Not Yet Recruiting |
| Boston Children's Hospita | Boston, Massachusetts, United States | Not Yet Recruiting |
+ 14 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07450547